annual accounts payable:
$48.45M+$33.87M(+232.16%)Summary
- As of today (June 22, 2025), PCVX annual accounts payable is $48.45 million, with the most recent change of +$33.87 million (+232.16%) on December 31, 2024.
- During the last 3 years, PCVX annual accounts payable has risen by +$41.69 million (+616.96%).
- PCVX annual accounts payable is now at all-time high.
Performance
PCVX Accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly accounts payable:
$20.51M-$27.94M(-57.66%)Summary
- As of today (June 22, 2025), PCVX quarterly accounts payable is $20.51 million, with the most recent change of -$27.94 million (-57.66%) on March 31, 2025.
- Over the past year, PCVX quarterly accounts payable has dropped by -$1.20 million (-5.54%).
- PCVX quarterly accounts payable is now -57.66% below its all-time high of $48.45 million, reached on December 31, 2024.
Performance
PCVX quarterly accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
PCVX Accounts payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +232.2% | -5.5% |
| 3 y3 years | +617.0% | +327.3% |
| 5 y5 years | +1335.2% | +674.1% |
PCVX Accounts payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +617.0% | -57.7% | +327.3% |
| 5 y | 5-year | at high | +1335.2% | -57.7% | +702.6% |
| alltime | all time | at high | +1612.1% | -57.7% | +702.6% |
PCVX Accounts payable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $20.51M(-57.7%) |
| Dec 2024 | $48.45M(+232.2%) | $48.45M(+165.9%) |
| Sep 2024 | - | $18.22M(+74.1%) |
| Jun 2024 | - | $10.47M(-51.8%) |
| Mar 2024 | - | $21.72M(+48.9%) |
| Dec 2023 | $14.59M(+48.9%) | $14.59M(-7.1%) |
| Sep 2023 | - | $15.70M(-3.5%) |
| Jun 2023 | - | $16.27M(+40.0%) |
| Mar 2023 | - | $11.62M(+18.6%) |
| Dec 2022 | $9.79M | $9.79M(+78.6%) |
| Sep 2022 | - | $5.49M(-22.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $7.04M(+46.6%) |
| Mar 2022 | - | $4.80M(-29.0%) |
| Dec 2021 | $6.76M(-77.3%) | $6.76M(-73.7%) |
| Sep 2021 | - | $25.71M(+8.5%) |
| Jun 2021 | - | $23.70M(-25.6%) |
| Mar 2021 | - | $31.86M(+7.0%) |
| Dec 2020 | $29.79M(+782.3%) | $29.79M(+178.8%) |
| Sep 2020 | - | $10.69M(+318.0%) |
| Jun 2020 | - | $2.56M(-3.5%) |
| Mar 2020 | - | $2.65M(-21.5%) |
| Dec 2019 | $3.38M(+19.3%) | $3.38M |
| Dec 2018 | $2.83M | - |
FAQ
- What is Vaxcyte annual accounts payable?
- What is the all time high annual accounts payable for Vaxcyte?
- What is Vaxcyte annual accounts payable year-on-year change?
- What is Vaxcyte quarterly accounts payable?
- What is the all time high quarterly accounts payable for Vaxcyte?
- What is Vaxcyte quarterly accounts payable year-on-year change?
What is Vaxcyte annual accounts payable?
The current annual accounts payable of PCVX is $48.45M
What is the all time high annual accounts payable for Vaxcyte?
Vaxcyte all-time high annual accounts payable is $48.45M
What is Vaxcyte annual accounts payable year-on-year change?
Over the past year, PCVX annual accounts payable has changed by +$33.87M (+232.16%)
What is Vaxcyte quarterly accounts payable?
The current quarterly accounts payable of PCVX is $20.51M
What is the all time high quarterly accounts payable for Vaxcyte?
Vaxcyte all-time high quarterly accounts payable is $48.45M
What is Vaxcyte quarterly accounts payable year-on-year change?
Over the past year, PCVX quarterly accounts payable has changed by -$1.20M (-5.54%)